- Consumer Products
- Latest 135.45
- Currency US$
- Change -0.77
- Percent Change -0.565 %
- Volume 1,123,011
- Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jan 28||$0.44||Apr 22||$0.44|
12 months ended Apr 20, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.